The mission of NNECOS is to promote the highest quality care for patients with cancer and blood disorders in our region through professional networking, education, and scientific research, as well as patient advocacy and public policy.

HONORING THE MEMORIY OF DR. STEVEN GRUNBERG

As we look back at the milestones in NNECOS’ 30-year history, we also remember the people. We honor the memory of friend and long-time NNECOS leader, Dr. Steven Grunberg.

CANCER COMMUNITY SUPPORT


NNECOS Helps

Please read this special message to our community.

NNECOS News

NNECOS News

Industry-Sponsored Regional Education & Initiatives

Latest FDA Approvals And Drug-Related Updates

Latest FDA Approvals

  • Aug 13 - FDA approves belzutifan for cancers associated with von Hippel-Lindau disease
  • Aug 17 - FDA grants accelerated approval to dostarlimab-gxly for dMMR advanced solid tumors
  • Aug 19 - FDA approves nivolumab for adjuvant treatment of urothelial carcinoma
  • Aug 25 - FDA approves ivosidenib for advanced or metastatic cholangiocarcinoma
  • Aug 31 - FDA approves zanubrutinib for Waldenstr├Âm’s macroglobulinemia
  • Sep 14 - FDA grants accelerated approval to zanubrutinib for marginal zone lymphoma
  • Sep 15 - FDA grants accelerated approval to mobocertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations
  • Sep 17 - FDA approves cabozantinib for differentiated thyroid cancer
  • Sep 20 - FDA grants accelerated approval to tisotumab vedotin-tftv for recurrent or metastatic cervical cancer
  • Sep 22 - FDA approves ruxolitinib for chronic graft-versus-host disease

Package/Label Updates

Code Updates

  • Oct 1 - J-code J9247 for Pepaxto┬« (melphalan flufenamide) injection, 1mg.

Other Updates

New Job Posted - NNECOS Classifieds

  • Northern Light Health Eastern Maine Medical Center is seeking a board-certified/board eligible hematologist/oncologist
  • UVM Medical Center is seeking a physician with experience in hematologic malignancies, autologous stem cell transplantation and CAR-T cell therapy
  • Multiple Positions - New England Cancer Specialists Maine & New Hampshire

COVID SURVEY AND RESOURCES

ASCO Survey on COVID in Oncology Registry

The aim is to help the cancer community learn more about the patterns of symptoms & severity of COVID among patients with cancer, as well as the impact on delivery of cancer care & patient outcomes. Periodic reports will deliver real-time information to the oncology community.

ASCO COVID Resource Page

COVID Info & Resources including a Fact Sheet on EUA of BAmlanivimab

State Advocacy

ASCO Twitter Feeds

SOCIAL MEDIA

 

Upcoming events

SHARE WITH NNECOS


Do you have an idea, suggestion, or other feedback you'd like to share? Comment, concern or compliment? Reach out and

Share with NNECOS.

We'd love to hear from you! 

Thank You Corporate Members!


Group Practice Members

Because your entire team benefits
from being a part of NNECOS!

Looking Back!

Enjoy this wonderful interview with 3 of NNECOS' founding members!




Special thanks to our 2021 Diamond & Platinum Corporate Members!

  
  
  
  
  

Platinum Members

 

  
  
  
    
    
    
    

View the complete list of supporters.

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software